ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,887Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 393

$579K Total Retail Price of All Prescriptions

Rank: 46 out of 393

935 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 935 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

15% of this provider’s 935 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 14,206 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
SIMVASTATIN 1,005 931 1 1
OMEPRAZOLE 896 780 2 6
LEVOTHYROXINE SODIUM 890 793 3 3
LISINOPRIL 807 757 4 2
AMLODIPINE BESYLATE 635 593 5 4
METFORMIN HCL 513 429 6 7
HYDROCODONE-ACETAMINOPHEN 490 429 S3 7 5
ALENDRONATE SODIUM 488 468 8 16
ATENOLOL 415 361 9 13
LOSARTAN POTASSIUM 315 270 10 12
HYDROCHLOROTHIAZIDE 310 278 11 10
FUROSEMIDE 293 276 12 8
METOPROLOL TARTRATE 272 252 13 9
WARFARIN SODIUM 266 239 14 17
LOVASTATIN 265 238 15 14
GABAPENTIN 259 231 16 15
VENTOLIN HFA 211 203 17 42
POTASSIUM CHLORIDE 202 187 18 20
ZOLPIDEM TARTRATE 197 160 19 11
LOSARTAN-HYDROCHLOROTHIAZIDE 176 172 20 31
FLUTICASONE PROPIONATE 174 143 21 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 174 164 21 24
METOPROLOL SUCCINATE 166 154 23 22
GLIMEPIRIDE 161 123 24 39
PRAVASTATIN SODIUM 155 154 25 18
RANITIDINE HCL 149 143 26 29
CLOPIDOGREL 132 115 27 33
TAMSULOSIN HCL 128 124 28 25
FINASTERIDE 124 112 29 60
TRAMADOL HCL 119 115 30 30
TERAZOSIN HCL 117 105 31 38
GEMFIBROZIL 113 90 32 62
ACTOS 112 100 33 78
CARVEDILOL 112 112 33 21
SPIRIVA 111 107 35 41
ATORVASTATIN CALCIUM 109 78 36 19
NIFEDIPINE ER 107 107 37 91
FENOFIBRATE 104 79 38 43
CITALOPRAM HBR 102 71 39 23
DILTIAZEM ER 102 102 39 107
PLAVIX 99 92 41 51
OXYBUTYNIN CHLORIDE 93 71 42 90
GLIPIZIDE 90 72 43 32
SYMBICORT 89 72 44 96
TRIAMTERENE-HCTZ 89 85 44 49
QVAR 87 85 46 101
HYDRALAZINE HCL 81 75 47 64
IBUPROFEN 75 52 48 55
BENAZEPRIL HCL 72 60 49 40
VERAPAMIL ER 72 55 49 86
AMOX TR-POTASSIUM CLAVULANATE 67 55 51 100
BENICAR HCT 63 63 52 161
EVISTA 62 62 53 98
CLONIDINE HCL 60 54 54 50
ALLOPURINOL 60 59 54 26
NAPROXEN 59 34 56 85
OXYBUTYNIN CHLORIDE ER 59 53 56 122
LANTUS 57 48 58 73
OXYCODONE HCL 57 18 S2 58 36
DILTIAZEM 24HR ER 52 47 60 129
PIOGLITAZONE HCL 51 43 R 61 173
GLYBURIDE 51 51 R 61 46
SERTRALINE HCL 50 40 63 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 17, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.